EVEREST, NCT01276457: Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients |
|
|
| Completed | 3 | 223 | Europe | Everolimus 0.25 and 0.75 mg tablets, Cyclosporine very low dose (150-300 ng/mL) microemulsion, Neoral, Cyclosporine low dose (350-500 ng/mL) microemulsion | Novartis Pharmaceuticals | Transplantation Infection | 02/09 | 02/09 | | |
NCT00149890 / 2015-003528-29: Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroids |
|
|
| Completed | 3 | 77 | Europe | Basiliximab, Simulect®, Cyclosporine/cyclosporine microemulsion, Sandimmun®/Sandimmun® Optoral, Steroid | Novartis | Liver Transplantation, Infection | 03/09 | 03/09 | | |
NCT00075478: Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer |
|
|
| Completed | 3 | 87 | US, Europe | Total-Body Irradiation, TBI, Total Body Irradiation, Whole-Body Irradiation, Fludarabine Phosphate, 2-F-ara-AMP, Beneflur, SH T 586, Mycophenolate Mofetil, Cellcept, MMF, Cyclosporine, 27-400, CsA, Neoral, OL 27-400, Sandimmun, Peripheral Blood Stem Cell Transplantation, PBPC transplantation, Peripheral Blood Progenitor Cell Transplantation, Peripheral Stem Cell Support, Peripheral Stem Cell Transplantation | Fred Hutchinson Cancer Center, National Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Diffuse Large B-Cell Lymphoma, Hematopoietic and Lymphoid Cell Neoplasm, Indolent Non-Hodgkin Lymphoma, Mantle Cell Lymphoma, Myelodysplastic/Myeloproliferative Neoplasm, Plasma Cell Myeloma, Refractory Chronic Lymphocytic Leukemia, Refractory Hodgkin Lymphoma, Waldenstrom Macroglobulinemia | 02/14 | 02/14 | | |
NCT00919815: Ciclosporin in the Management of New Type 1 Reactions in Leprosy |
|
|
| Completed | 2/3 | 73 | RoW | Ciclosporin, Cyclosporine, Cyclosporine A, Prednisolone, corticosteroids | London School of Hygiene and Tropical Medicine, Homes and Hospitals of St Giles, Alert Hospital, Ethiopia, Armauer Hansen Research Institute, Ethiopia | Leprosy | 12/12 | 07/13 | | |